Cell and Gene Therapies in Transit: Caution – Hazards Ahead: The Cell & Gene Therapy Manufacturing Pathway – Part 2

Kevin O’Donnell.  Cell and Gene Therapies in Transit: Caution – Hazards Ahead: The Cell & Gene Therapy Manufacturing Pathway – Part 2.  Cell and Gene Therapy Insights. 2016; 2(2), 271-276.  doi: 10.18609/cgti.2016.031

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.